Related Experiment Video
Updated: Feb 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
TRPS1 Suppresses Breast Cancer Epithelial-mesenchymal Transition Program as a Negative Regulator of SUZ12
Jing Hu1, Peng Su2, Meng Jiao1
1Department of Pathology, Shandong University, School of Basic Medicine, Jinan, 250012, China.
Abstract:
Breast cancer (BC) is among the most common malignant diseases and metastasis is the handcuff of treatment. Cancer metastasis is a multistep process associated with the epithelial-mesenchymal transition (EMT) program. Several studies have demonstrated that transcriptional repressor GATA binding 1 (TRPS1) played important roles in development and progression of primary BC. In this study we sought to identify the mechanisms responsible for this function of TRPS1 in the continuum of the metastatic cascade. Here we described that TRPS1 was significantly associated with BC metastasis using public assessable datasets. Clinically, loss of TRPS1 expression in BC was related to higher histological grade. In vitro functional study and bioinformatics analysis revealed that TRPS1 inhibited cell migration and EMT in BC. Importantly, we identified SUZ12 as a novel target of TRPS1 related to EMT program. ChIP assay demonstrated TRPS1 directly inhibited SUZ12 transcription by binding to the SUZ12 promoter. Loss of TRPS1 resulted in increased SUZ12 binding and H3K27 tri-methylation at the CDH1 promoter and repression of E-cadherin. In all, our data indicated that TRPS1 maintained the expression of E-cadherin by inhibiting SUZ12, which might provide novel insight into how loss of TRPS1 contributed to BC progression.
Insights
Transcriptional repressor GATA binding 1 (TRPS1) inhibits breast cancer (BC) metastasis by suppressing SUZ12. Loss of TRPS1 increases SUZ12, leading to E-cadherin repression and promoting BC progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Breast cancer (BC) metastasis remains a significant challenge in treatment.
- The epithelial-mesenchymal transition (EMT) program is crucial for cancer metastasis.
- Transcriptional repressor GATA binding 1 (TRPS1) is implicated in primary BC development and progression.
Purpose of the Study:
- To elucidate the mechanisms by which TRPS1 influences the metastatic cascade in breast cancer.
- To identify novel targets of TRPS1 involved in BC metastasis and EMT.
Main Methods:
- Analysis of public breast cancer datasets.
- In vitro functional studies assessing cell migration and EMT.
- Bioinformatics analysis and Chromatin Immunoprecipitation (ChIP) assays.
- Investigation of SUZ12 and E-cadherin regulation.
Main Results:
- TRPS1 expression loss correlates with higher BC histological grade and increased metastasis.
- TRPS1 was found to inhibit BC cell migration and EMT.
- TRPS1 directly represses SUZ12 transcription.
- Loss of TRPS1 leads to increased SUZ12 binding and H3K27 tri-methylation at the CDH1 promoter, causing E-cadherin repression.
Conclusions:
- TRPS1 maintains E-cadherin expression by inhibiting SUZ12, thus suppressing BC metastasis.
- The TRPS1-SUZ12-E-cadherin axis offers new insights into BC progression.
- Targeting this pathway may present novel therapeutic strategies for metastatic breast cancer.
Related Concept Videos
Negative Regulator Molecules
Phase Transitions
Phase Transitions: Sublimation and Deposition
Phase Transitions: Melting and Freezing
Properties of Transition Metals
Phase Transitions: Vaporization and Condensation

